Caesar & Loretz GmbH (Caelo) is a traditional company with a rich 135-year history and a strong reputation for quality in the Health Care and Pharmaceutical industries. Caelo has established itself as a key player in the creation and maintenance of the foundations for personalized medicine, supplying basic pharmaceutical ingredients to pharmacies and hospitals. Notably, the company is also involved in the manufacturing of ointments, ointment bases, oils, herbal raw materials, and tea mixtures, showcasing a diverse product portfolio. With its head office in Hilden and an additional production site in Bonn, Caelo operates with a team of approximately 250 workers across these locations. The company holds a manufacturing authorization in accordance with § 13 of the German Pharmaceuticals Act and maintains GMP certification at both sites. Strict quality control measures are implemented, with all active and auxiliary excipients being examined by in-house laboratories. Caelo also provides batch-related certificates of analysis, in-house test instructions, and safety data sheets for its products. Caelo's proficiency extends to the market for medical cannabis and its ingredients, where the company has significant know-how as a service provider. Through its operations, Caelo is committed to the responsibility for individuals relying on high-quality health solutions and for its partners in pharmacies, hospitals, wholesalers, and industry. Despite the absence of recent investment information, Caelo's long-standing presence and dedication to quality position it as a noteworthy player in the pharmaceutical and healthcare sectors.
There is no investment information
No recent news or press coverage available for Caesar & Loretz GmbH (Caelo).